Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

South Korea · Delayed Price · Currency is KRW

64,900

+300 (0.46%)

Sep 23, 2026, 3:30 PM KST

Market Cap	855.13B -21.9%
Revenue (ttm)	1.78T +7.1%
Net Income	79.47B +30.3%
EPS	5,977.21 +29.3%
Shares Out	13.18M
PE Ratio	10.86
Forward PE	12.68
Dividend	500.00 (0.77%)
Ex-Dividend Date	Dec 29, 2025

Volume	16,584
Open	64,000
Previous Close	64,600
Day's Range	64,000 - 65,400
52-Week Range	63,000 - 98,100
Beta	0.25
Analysts	Buy
Price Target	102,857.14 (+58.49%)
Est. Earnings	Oct 26, 2026

About KRX:185750

Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1941

Employees 2,170

Stock Exchange Korea Stock Exchange

Ticker Symbol 185750

Full Company Profile

Financial Performance

In 2025, KRX:185750's revenue was 1.69 trillion, an increase of 6.68% compared to the previous year's 1.59 trillion. Earnings were 77.51 billion, a decrease of -28.94%.

Financial Statements

Analyst Summary

According to 7 analysts, the average rating for 185750 stock is "Buy." The 12-month stock price target is ₩102,857, which is an increase of 58.49% from the latest price.

Price Target

₩102,857

(58.49% upside)

Analyst Consensus: Buy

Stock Forecasts